ArticleDiabetic medicine : a journal of the British Diabetic Association2026
Prognostic value of triglyceride-derived metabolic parameters for micro- and macrovascular complications and mortality in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study.
Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The association between the triglyceride-glucose index and diabetic peripheral neuropathy: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimsTriglyceride-derived metabolic parameters have been proposed as indirect measures of insulin resistance and also as predictors of worse prognosis, mainly in Asian populations. However, their value as risk predictors of micro- and macrovascular complications in non-Asian individuals with type 2 diabetes is uncertain.
methodsTriglyceride-derived parameters, the atherogenic index of plasma (AIP, the triglyceride/HDL-cholesterol ratio), the triglyceride-glucose index (TyG, the triglyceride-fasting glucose product) and the TyG*BMI were calculated at baseline and during the 1st year of follow-up in a prospective cohort of 667 individuals with type 2 diabetes. Multivariable Cox analyses assessed the associations between triglyceride-derived parameters (as continuous and categorical tertile variables) and cardiovascular (total and major cardiovascular events) and microvascular (renal, retinopathy and peripheral neuropathy events) outcomes and mortality.
resultsOver a median 10.6 years of follow-up, there were 212 total cardiovascular events (172 major ones), 263 all-cause deaths and 124 new microalbuminuria developments, 98 advanced renal function deteriorations, 154 retinopathy and 173 peripheral neuropathy development/progression events. None of the triglyceride-derived metabolic parameters, either analysed as continuous or categorical variables, were associated with significantly higher risks for any of the adverse outcomes. The best predictive performance was the 1st year TyG for retinopathy development/progression (HR: 1.24; 95%CI: 1.01-1.53, for increments of 1-SD), which attenuated to non-significant (HR: 1.16; 95%CI: 0.92-1.45) after further adjustment for serum LDL-cholesterol levels.
conclusionsNo triglyceride-derived metabolic parameter was predictive of any adverse outcome, either micro- or macrovascular events or mortality, suggesting that they should not be used for risk stratification in individuals with type 2 diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.